| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Craig McClain | |
| Ming Song | |||
| A James Hanje | |||
| Daniell Hill | |||
| Brett Fortune | |||
| P2860 | cites work | A review of plants used in the treatment of liver disease: part 1 | Q77690751 |
| Plasma copper and zinc levels in chronic viral hepatitis | Q80476435 | ||
| [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial] | Q80491948 | ||
| Serum copper and zinc concentrations in patients with chronic hepatitis C | Q81889802 | ||
| Serum copper and zinc concentrations in patients with chronic hepatitis B | Q81889805 | ||
| Zinc absorption in alcoholics using zinc-65 | Q93647318 | ||
| Adulterants in Asian patent medicines | Q93912423 | ||
| Effects of singly administered betaine on hepatotoxicity of chloroform in mice | Q77291845 | ||
| Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients | Q77318114 | ||
| Inhibition of the superoxide anion release and hydrogen peroxide formation in PMNLs by flavonolignans | Q77360977 | ||
| Betaine reduces hepatic lipidosis induced by carbon tetrachloride in Sprague-Dawley rats | Q77432486 | ||
| Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression | Q28367828 | ||
| Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver | Q28581508 | ||
| S-adenosylmethionine synthesis: molecular mechanisms and clinical implications | Q28646532 | ||
| Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey | Q29547851 | ||
| Unconventional medicine in the United States. Prevalence, costs, and patterns of use | Q29615130 | ||
| High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin | Q33209400 | ||
| Podophyllotoxin intoxication: toxic effect of Bajiaolian in herbal therapeutics | Q33352519 | ||
| Potential interactions between alternative therapies and warfarin | Q33973047 | ||
| Hypomagnesemia, a risk factor in diabetic retinopathy | Q34057134 | ||
| Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature | Q34062560 | ||
| Cytokines in alcoholic and nonalcoholic steatohepatitis | Q34082594 | ||
| State of the arg: protein methylation at arginine comes of age. | Q34084396 | ||
| Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review | Q34091131 | ||
| Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity | Q34127332 | ||
| CYP2E1: Biochemistry, Toxicology, Regulation and Function in Ethanol-Induced Liver Injury | Q34267467 | ||
| Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease | Q34315189 | ||
| Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed rats | Q34317982 | ||
| Betaine in human nutrition | Q34342373 | ||
| S-Adenosylmethionine and methylation | Q34382111 | ||
| Zinc acetate for the treatment of Wilson's disease | Q34390366 | ||
| Review article: glycyrrhizin as a potential treatment for chronic hepatitis C. | Q34466343 | ||
| Treatment of Wilson's disease with zinc: XV long-term follow-up studies | Q34477827 | ||
| Acute hepatitis induced by greater celandine (Chelidonium majus). | Q34505490 | ||
| Fasting plasma magnesium concentrations and glucose disposal in diabetes | Q34551957 | ||
| Mechanisms of non-alcoholic steatohepatitis | Q34554507 | ||
| DNA methylation and the regulation of gene transcription | Q34578086 | ||
| A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. | Q34675881 | ||
| Alcohol and mitochondria: a dysfunctional relationship | Q34676867 | ||
| Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. | Q34680641 | ||
| S-Adenosylmethionine revisited: its essential role in the regulation of liver function | Q34774382 | ||
| S-Adenosylmethionine, cytokines, and alcoholic liver disease | Q34774401 | ||
| Nonalcoholic fatty liver disease: relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. | Q34799265 | ||
| Black cohosh and other herbal remedies associated with acute hepatitis | Q34967225 | ||
| Zinc supplementation prevents alcoholic liver injury in mice through attenuation of oxidative stress | Q35083910 | ||
| Advances in alcoholic liver disease | Q35163801 | ||
| Structure, function and evolution of CpG island promoters | Q35541032 | ||
| Workshop overview: Hepatotoxicity assessment for botanical dietary supplements | Q35672062 | ||
| Kava kava: examining new reports of toxicity | Q35739869 | ||
| A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production | Q35791916 | ||
| Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease | Q35872557 | ||
| Use of herbal supplements for chronic liver disease | Q35954419 | ||
| Nutritional supplements and alternative medicine. | Q36036473 | ||
| Zinc prevention and treatment of alcoholic liver disease | Q36228734 | ||
| Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies | Q36683219 | ||
| Short-term administration of (-)-epigallocatechin gallate reduces hepatic steatosis and protects against warm hepatic ischemia/reperfusion injury in steatotic mice. | Q38330451 | ||
| Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice | Q38354947 | ||
| Hepatoprotective effects of 18beta-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression | Q38522082 | ||
| Influence of Silybin-dihemisuccinate on fatty acid synthesis in rat liver (author's transl) | Q39273434 | ||
| Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 | Q24564855 | ||
| A practice guideline on Wilson disease | Q28207512 | ||
| Alternative medicine--the risks of untested and unregulated remedies | Q28282511 | ||
| Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age | Q28283140 | ||
| Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality | Q28292632 | ||
| The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis | Q28345942 | ||
| Chaparral-associated hepatotoxicity | Q39454709 | ||
| Treatment of Wilson's disease | Q39703387 | ||
| Zinc metabolism in alcoholic liver disease | Q39757000 | ||
| Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. | Q40422604 | ||
| S-adenosylhomocysteine sensitizes to TNF-alpha hepatotoxicity in mice and liver cells: a possible etiological factor in alcoholic liver disease | Q40512960 | ||
| Effects of herbal compound 861 on human hepatic stellate cell proliferation and activation | Q40521378 | ||
| Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons | Q40560432 | ||
| Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. | Q40607975 | ||
| Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. | Q40654530 | ||
| Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model | Q40985547 | ||
| Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways | Q40986660 | ||
| Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. | Q41013799 | ||
| Zinc supplementation in alcoholic cirrhosis. A double-blind clinical trial. | Q41043341 | ||
| Effects of glycyrrhizin on immune-mediated cytotoxicity | Q41122142 | ||
| Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding | Q41277746 | ||
| The neurobiology of hepatic encephalopathy | Q41302077 | ||
| Magnesium and liver cirrhosis: a hypothesis | Q41503072 | ||
| Milk thistle (Silybum marianum) for the therapy of liver disease | Q41703272 | ||
| Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study | Q41739541 | ||
| Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline | Q41916987 | ||
| Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients | Q42437587 | ||
| Altered ionic effects of insulin in hypertension: role of basal ion levels in determining cellular responsiveness. | Q42439266 | ||
| Betaine lowers elevated s-adenosylhomocysteine levels in hepatocytes from ethanol-fed rats | Q42446887 | ||
| Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats | Q42465673 | ||
| A Korean herbal medicine, Panax notoginseng, prevents liver fibrosis and hepatic microvascular dysfunction in rats | Q42474065 | ||
| Safety of complementary medicines should be monitored | Q42878359 | ||
| Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus | Q42987918 | ||
| Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial | Q42995489 | ||
| Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study | Q42995972 | ||
| Zinc supplementation enhances the response to interferon therapy in patients with chronic hepatitis C. | Q43034289 | ||
| Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis | Q43037257 | ||
| Plasma and urinary zinc in patients with malabsorption syndromes or hepatic cirrhosis | Q43250341 | ||
| Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent--experimental & clinical studies | Q43483933 | ||
| Plasma zinc concentration in liver diseases. Comparison with normal controls and certain other chronic diseases | Q43530660 | ||
| Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial. | Q43542079 | ||
| 'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients | Q43669351 | ||
| Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study | Q43742730 | ||
| Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study | Q43746141 | ||
| Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer | Q43761430 | ||
| Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C. | Q43871989 | ||
| Effect of glycyrrhizin on lysis of hepatocyte membranes induced by anti-liver cell membrane antibody | Q43904475 | ||
| Attenuation of bacterial lipopolysaccharide-induced hepatotoxicity by betaine or taurine in rats | Q43917249 | ||
| Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage | Q44042283 | ||
| Efficacy of Stronger Neo-Minophagen C compared between two doses administered three times a week on patients with chronic viral hepatitis | Q44230350 | ||
| Prevention of alterations in intestinal permeability is involved in zinc inhibition of acute ethanol-induced liver damage in mice | Q44355541 | ||
| Effect of the flavanolignans of Silybum marianum L. On lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes | Q44455332 | ||
| Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. | Q44527604 | ||
| Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B. | Q44535161 | ||
| Involvement of intracellular glutathione in zinc deficiency-induced activation of hepatic stellate cells | Q44539220 | ||
| Primary human hepatocytes are protected against prolonged and repeated exposure to ethanol by silibinin-dihemisuccinate | Q44547401 | ||
| Silibinin protects mice from T cell-dependent liver injury | Q44555689 | ||
| Hepatic mitochondrial glutathione depletion and progression of experimental alcoholic liver disease in rats | Q44580088 | ||
| S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice☆ | Q44617752 | ||
| Protection by hot water extract of Panax notoginseng on chronic ethanol‐induced hepatotoxicity | Q44640785 | ||
| Glycyrrhizin enhances interleukin-10 production by liver dendritic cells in mice with hepatitis | Q44653804 | ||
| A randomized placebo controlled trial of vitamin E for alcoholic hepatitis | Q44691206 | ||
| Vitamin E treatment in pediatric obesity-related liver disease: a randomized study | Q44694111 | ||
| Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis | Q44743733 | ||
| A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis | Q44907394 | ||
| Prospective study of chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-9). | Q45101191 | ||
| Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial | Q45310078 | ||
| A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study | Q45336183 | ||
| Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis | Q45337315 | ||
| Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus-associated cirrhosis and HCC. | Q45764849 | ||
| Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication | Q45765030 | ||
| Malnutrition in alcoholic and virus-related cirrhosis | Q45771474 | ||
| Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro | Q45779102 | ||
| A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. | Q46214913 | ||
| The effect of zinc supplementation on the treatment of chronic hepatitis C patients with interferon and ribavirin | Q46499178 | ||
| Hypomagnesemia, insulin resistance, and non-alcoholic steatohepatitis in obese subjects | Q46540391 | ||
| Magnesium supplementation and muscle function in patients with alcoholic liver disease: a randomized, placebo-controlled trial | Q46712195 | ||
| NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis | Q46802365 | ||
| Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis | Q47176613 | ||
| Magnesium deficiency produces insulin resistance and increased thromboxane synthesis | Q47566285 | ||
| Magnesium depletion in chronic terminal liver cirrhosis | Q49046981 | ||
| Zinc absorption and leukocyte zinc in alcoholic and nonalcoholic cirrhosis | Q49137267 | ||
| Preliminary report of a randomized, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C. | Q50891834 | ||
| Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. | Q50892403 | ||
| Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. | Q50925888 | ||
| Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. | Q51593279 | ||
| Protein energy malnutrition in severe alcoholic hepatitis: diagnosis and response to treatment. The VA Cooperative Study Group #275. | Q52336524 | ||
| Alcohol-induced regulation of nuclear regulatory factor-kappa beta in human monocytes. | Q52527307 | ||
| Studies on the regenerative capacity of the liver in rats subjected to partial hepatectomy and treated with silymarin | Q52955917 | ||
| The long term efficacy of glycyrrhizin in chronic hepatitis C patients. | Q53444006 | ||
| Plasma cysteine, cystine, and glutathione in cirrhosis. | Q53754506 | ||
| S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. | Q55033177 | ||
| Indinavir concentrations and St John's wort. | Q55033637 | ||
| Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver | Q56224573 | ||
| Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis | Q57821702 | ||
| A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy | Q57999113 | ||
| The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification | Q58487609 | ||
| Hepatic Phosphatidylethanolamine Methyltransferase Activity Is Decreased by Ethanol and Increased by Phosphatidylcholine | Q61785760 | ||
| Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis | Q67555815 | ||
| S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury | Q67555817 | ||
| Antihepatotoxic properties of picroliv: an active fraction from rhizomes of Picrorhiza kurrooa | Q67784175 | ||
| Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme | Q67808796 | ||
| Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis | Q67970200 | ||
| [Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance] | Q68003208 | ||
| Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver | Q68019152 | ||
| Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study | Q68512879 | ||
| S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon | Q68716606 | ||
| The neutralization of hydroxyl radical by silibin, sorbinil and bendazac | Q68852798 | ||
| Effect of glycyrrhizin on lysosomes labilization by phospholipase A2 | Q69710401 | ||
| S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial | Q70261113 | ||
| VA cooperative study on alcoholic hepatitis. II: Prognostic significance of protein-calorie malnutrition | Q70276716 | ||
| Effects of zinc deficiency on ethanol metabolism and alcohol and aldehyde dehydrogenase activities | Q70382740 | ||
| Evidence for impairment of transsulfuration pathway in cirrhosis | Q70871879 | ||
| Oral zinc therapy for Wilson's disease | Q71022120 | ||
| Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis | Q71057911 | ||
| Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease | Q71152805 | ||
| Protection by silibinin against Amanita phalloides intoxication in beagles | Q71341368 | ||
| S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine | Q71364484 | ||
| Association between reactive oxygen species and disease activity in chronic hepatitis C | Q71651291 | ||
| [A possible mechanism of interstitial pneumonia during interferon therapy with sho-saiko-to] | Q71698331 | ||
| Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: effect of S-adenosylmethionine treatment | Q71739426 | ||
| Scavenging of reactive oxygen species by silibinin dihemisuccinate | Q72174184 | ||
| Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors | Q72282193 | ||
| Effects of long-term vitamin E supplementation in alcoholic cirrhotics | Q72334508 | ||
| Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis | Q72522975 | ||
| Urine and Serum Zinc Abnormalities in Disease of the Liver | Q72581145 | ||
| Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial | Q72586697 | ||
| Management of hepatic encephalopathy with oral zinc supplementation: a long-term treatment | Q72649584 | ||
| Interferon Induction by Glycyrrhizin and Glycyrrhetinic Acid in Mice | Q72961054 | ||
| [Autoimmune hepatitis with drug-induced pneumonia due to Sho-saiko-to] | Q73016575 | ||
| Antioxidants attenuate nuclear factor-kappa B activation and tumor necrosis factor-alpha production in alcoholic hepatitis patient monocytes and rat Kupffer cells, in vitro | Q73310303 | ||
| Dietary and nutritional abnormalities in alcoholic liver disease: a comparison with chronic alcoholics without liver disease | Q73335369 | ||
| The protective effect of glycyrrhizin on anti-Fas antibody-induced hepatitis in mice | Q73390774 | ||
| Effects of the Japanese herbal medicine "Sho-saiko-to" (TJ-9) on in vitro interleukin-10 production by peripheral blood mononuclear cells of patients with chronic hepatitis C | Q73420907 | ||
| Acute heart transplant rejection due to Saint John's wort | Q73465831 | ||
| Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis | Q73792877 | ||
| Interaction of liver methionine adenosyltransferase with hydroxyl radical | Q73804234 | ||
| The possible role of zinc and metallothionein in the liver on the therapeutic effect of IFN-alpha to hepatitis C patients | Q73860740 | ||
| Effects of CH-100, a chinese herbal medicine, on acute concanavalin A-mediated hepatitis in control and alcohol-fed rats | Q73974846 | ||
| Trace elements and chronic liver diseases | Q74090156 | ||
| Effects of silibinin and of a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts | Q74119589 | ||
| Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C: a randomized, double-blind, placebo-controlled study | Q74141609 | ||
| Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laënnec's cirrhosis and their validation by sequential analysis | Q74220627 | ||
| Acute hepatitis in a patient using a Chinese herbal tea--a case report | Q74425879 | ||
| Zinc metabolism in hepatic dysfunction. II. Correlation of metabolic patterns with biochemical findings | Q74699522 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 255-272 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Nutrition in Clinical Practice | Q7070513 |
| P1476 | title | The use of selected nutrition supplements and complementary and alternative medicine in liver disease | |
| P478 | volume | 21 |
| Q37834051 | Alcoholic liver disease and malnutrition |
| Q45268831 | Antioxidants in the treatment of chronic liver diseases: why is the efficacy evidence so weak in humans? |
| Q37061693 | Complementary and alternative medicine use in chronic liver disease patients |
| Q26752622 | Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities |
| Q46834318 | Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial. |
| Q38058001 | Neurological complications post-liver transplantation: impact of nutritional status. |
| Q41873464 | Nutrition in Patients With Cirrhosis |
| Q36506081 | Nutrition in alcoholic liver disease |
| Q26769622 | Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination? |
| Q36506091 | Parenteral nutrition-associated liver disease in adult and pediatric patients |
| Q38102732 | Plant-based foods as a source of lipotropes for human nutrition: a survey of in vivo studies |
| Q26753151 | Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015 |
| Q36388498 | Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling |
| Q38271790 | The role of iron in alcohol-mediated hepatocarcinogenesis |
Search more.